News tagged with pseudomonas

Inhaler approved for cystic fibrosis patients

(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...

Mar 25, 2013
popularity not rated yet | comments 0

Parallel evolution - cystic fibrosis

(Medical Xpress) -- Researchers at the University of Liverpool are examining the evolution of Pseudomonas aeruginosa over time in the lungs of ten people with cystic fibrosis to understand why it persists ...

Mar 06, 2012
popularity 5 / 5 (3) | comments 0 | with audio podcast

An antibiotic effect minus resistance

After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval.

Oct 28, 2011
popularity 5 / 5 (3) | comments 0 | with audio podcast